Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 13 June, 2013 and appeared in  Type 2 DiabetesPsychiatryIssue 681

Association between Smoking and Depression in Type 2 Patients

Smoking and depression are strongly associated in patients with type 2 diabetes....

Advertisement

The study population for the trial included a total of 1,868 adults with type 2 diabetes. Smoking was assessed in the study with five different categories which included: never, former, light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day). Depression was assessed and categorized in the study using a Patient Health Questionnaire. Depression was classified in a binary fashion in this study and patients were recorded as either having no major depression or major depression syndrome. To make sense of the relationship between individual's smoking activity and the presence of depression a statistical analysis using a logistic regression was used, while controlling for other demographic and health-related variables.

After the procedures of the study were carried out, the results showed that major depression was indeed associated with an augmented likelihood of being a smoker in any of the categories (light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day)). Depression; however, was also increased in the patients having 2 or more diabetes complications, moderate-severe disability or having 2 or more other chronic illnesses. In the fully adjusted study model, having major depression was associated with an increased likelihood of being a moderate or heavy smoker (odds ratio = 2.62, 95% confidence interval = 1.43–4.81). The statistical analysis from the study also showed that the association between a light smoker and major depression was not significant when adjusting for confounding variables.

Researchers concluded that smoking and depression are strongly associated in patients with type 2 diabetes. The association between smoking and the presence of major depression syndrome was strongest for diabetic patients classified as either moderate or heavy smokers. These findings potentially mean that depression may be a significant consideration when targeting clients with diabetes who continue to smoke and optimal mental health may not be obtainable until smoking cessation is achieved.

Matthew Clyde, Geneviève Smith, Norbert Gariépy, et al. Canadian Journal of Diabetes. Association between Smoking and Depression in a Canadian Community-Based Sample with Type 2 Diabetes. Vol. 37, Issue 3, June 4, 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 June, 2013 and appeared in  Type 2 DiabetesPsychiatryIssue 681

Past five issues: Diabetes Clinical Mastery Series Issue 206 | SGLT-2 Inhibitors Special Edition September 2014 | Issue 746 | Diabetes Clinical Mastery Series Issue 205 | Humulin Insulin Special Edition September 2014 |

2014 Most Popular Articles:

Diabetic Neuropathy Improved with Vegan Diet
Posted August 22, 2014
Abbott Announces Approval of Its New Unique Continuous Glucose Monitor
Posted September 05, 2014
CDC: 40% of American Adults Will Develop Diabetes
Posted August 22, 2014
Low Carb Beats Low Fat
Posted September 05, 2014
Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies
Posted August 29, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
New Ultra-Rapid-Acting Insulin Formulation
Posted August 22, 2014
Pistachios Associated with an Improved Metabolic Risk Profile in Prediabetes
Posted August 29, 2014
Lilly's Basal Insulin Peglispro Demonstrated HbA1c Superiority against Lantus
Posted September 05, 2014
Sensor Implant Measures Blood pH in Type 1 Diabetes
Posted August 29, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Diabetes in Control is considering launching a store tab on the site with the ability to purchase A1C tests and other diagnostic test in bulk for medical professionals. What do you think?
CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: General Diabetes
Credits: .5
Search Articles On Diabetes In Control